A bill to amend the Controlled Substances Act to require the Attorney General to make procurement quotas for opioid analgesics publicly available, and for other purposes.
Opioid Quota Openness, Transparency, and Awareness Act of 2017 or the Opioid QuOTA Act This bill amends the Controlled Substances Act to require the Drug Enforcement Administration (DEA) to publish on its website certain information with respect to a registered manufacturer’s opioid procurement quota. It defines the term "opioid procurement quota" as a quota established by the DEA for the quantity of opioid analgesics that a registered manufacturer may procure.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Read twice and referred to the Committee on the Judiciary.
Crime and Law Enforcement
Congressional oversightDrug trafficking and controlled substancesGovernment information and archivesGovernment studies and investigationsLicensing and registrations
A bill to amend the Controlled Substances Act to require the Attorney General to make procurement quotas for opioid analgesics publicly available, and for other purposes.
USA115th CongressS-1882| Senate
| Updated: 9/28/2017
Opioid Quota Openness, Transparency, and Awareness Act of 2017 or the Opioid QuOTA Act This bill amends the Controlled Substances Act to require the Drug Enforcement Administration (DEA) to publish on its website certain information with respect to a registered manufacturer’s opioid procurement quota. It defines the term "opioid procurement quota" as a quota established by the DEA for the quantity of opioid analgesics that a registered manufacturer may procure.
Congressional oversightDrug trafficking and controlled substancesGovernment information and archivesGovernment studies and investigationsLicensing and registrations